MicroRNA-Based Liquid Biopsy for Cervical Cancer Diagnostics and Treatment Monitoring
Maria A Kepsha, Angelika V Timofeeva, Vasiliy S Chernyshev, Denis N Silachev, Elena A Mezhevitinova, Gennadiy T Sukhikh, Marco Ciotti · 2024
Read MicroRNA-Based Liquid Biopsy for Cervical Cancer Diagnostics and Treatment Monitoring by Maria A Kepsha, Angelika V Timofeeva, Vasiliy S Chernyshev, Denis N Silachev, Elena A Mezhevitinova, Gennadiy T Sukhikh, Marco Ciotti (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11678179.txt.
Description
Maria Kepsha and co-authors review blood tests based on microRNA for cervical cancer, in a review paper from 2024. The cancer is tied to human papillomavirus, and early finding lifts outcomes. Standard smear tests and virus tests have limits in accuracy and repeat results, so better tools are still needed.
A liquid biopsy checks cancer-linked material in blood or other fluids, with no cut to tissue. It can track tumor growth, spread, and response to care over time. Small RNA strands carried in tiny cell packets get special focus here. The review weighs their promise for screening and follow-up, and calls for more study.
Catalog record
| CREATOR | Maria A Kepsha, Angelika V Timofeeva, Vasiliy S Chernyshev, Denis N Silachev, Elena A Mezhevitinova, Gennadiy T Sukhikh, Marco Ciotti |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 48 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |